Health
Convalescent plasma is still in demand. But there are caveats – ABC News
This is a Kaiser Health News story.
Six months after it was controversially hailed by Trump administration officials as a breakthrough therapy to fight the worst effects of covid-19, convalescent plasma appears to be on the ropes.
The treatment that infuses blood plasma from recovered covid patients into people newly infected in hopes of boosting their immune response has not lived up to early hype. Some high-profile clinical trials have shown disappointing results. Demand from hospitals for the…
-
General15 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General18 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News17 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business15 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher